We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 10,000 results
  1. CNS-Specific Synthesis of Interleukin 23 Induces a Progressive Cerebellar Ataxia and the Accumulation of Both T and B Cells in the Brain: Characterization of a Novel Transgenic Mouse Model

    Interleukin 23 (IL-23) is a key mediator in neuroinflammation in numerous autoimmune diseases including multiple sclerosis (MS). However, the...

    Louisa Nitsch, Julian Zimmermann, ... Marcus Müller in Molecular Neurobiology
    Article 02 June 2019
  2. Increased circulating Th17 cell populations in patients with pancreatic ductal adenocarcinoma

    T-helper 17 (Th17) cells are a subset of CD4 + helper T cells that produce interleukin 17 (IL-17) and play a crucial role in the pathogenesis of...

    Imteyaz Ahmad Khan, Nidhi Singh, ... Anoop Saraya in Immunogenetics
    Article 04 August 2023
  3. Genetically Engineered Mesenchymal Stem Cell Therapy Against Murine Experimental Autoimmune Encephalomyelitis

    We used recombinant interleukin 23 receptor (RIL-23R)-engineered mesenchymal stem cells (MSCs) to study its therapeutic role in enhancing...

    Masoumeh Rostami, Kamran Haidari, ... Majid Shahbazi in Molecular Neurobiology
    Article 24 March 2022
  4. Trichinella spiralis cathepsin L induces macrophage M1 polarization via the NF-κB pathway and enhances the ADCC killing of newborn larvae

    Background

    During the early stages of Trichinella spiralis infection, macrophages predominantly undergo polarization to the M1-like phenotype,...

    Ruo Dan Liu, **ang Yu Meng, ... Zhong Quan Wang in Parasites & Vectors
    Article Open access 22 November 2023
  5. Allergic airway inflammation induces upregulation of the expression of IL-23R by macrophages and not in CD3 + T cells and CD11c+F4/80 dendritic cells of the lung

    Interleukin 23 and the interleukin 23 receptor (IL-23-IL23R) are described as the major enhancing factors for Interleukin 17 (IL-17) in allergic...

    Maximilian Leitner, Sebastian Heck, ... Quoc Thai Dinh in Cell and Tissue Research
    Article Open access 27 April 2022
  6. IL-23 contributes to Particulate Matter induced allergic asthma in the early life of mice and promotes asthma susceptibility

    Abstract

    Air pollutant exposure leads to and exacerbates respiratory diseases. Particulate Matter (PM) is a major deleterious factor in the...

    Heung-Woo Park, Hyun Seung Lee in Journal of Molecular Medicine
    Article 23 November 2023
  7. Interleukin-5 levels in relation to malaria severity: a systematic review

    Background

    The role of cytokines such as interleukin-5 (IL-5) in the pathogenesis of malaria remains unclear. This systematic review sought to...

    Manas Kotepui, Thitinat Duangchan, ... Kwuntida Uthaisar Kotepui in Malaria Journal
    Article Open access 03 August 2023
  8. IL-23 and the Tumor Microenvironment

    The tumor microenvironment (TME), which assists in the development, progression, and metastasis of malignant cells, is instrumental in virtually...
    Sweta Subhadarshani, Nabiha Yusuf, Craig A. Elmets in Tumor Microenvironment
    Chapter 2021
  9. Co-administration of probiotics and vitamin D reduced disease severity and complications in patients with Parkinson’s disease: a randomized controlled clinical trial

    Rationale

    Probiotics have beneficial effects on the nervous system by modulating the gut-brain axis. Additionally, vitamin D supplementation presents...

    Alireza Zali, Shirin Hajyani, ... Bahareh Pakpour in Psychopharmacology
    Article 28 May 2024
  10. Ameliorative effects of topical ramelteon on imiquimod-induced psoriasiform inflammation in mice

    Psoriasis is a long-lasting, immune-related inflammatory skin disease that affects 2–3% of the global population. It is distinguished by...

    Ahmed Wahhab Mohammed Khafaji, Adeeb Ahmed Kadhim Al-Zubaidy, ... Hayder Ridha Salman in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 06 March 2024
  11. Metabolic and inflammatory perturbation of diabetes associated gut dysbiosis in people living with and without HIV infection

    Background

    Gut dysbiosis has been linked with both HIV infection and diabetes, but its interplay with metabolic and inflammatory responses in...

    Kai Luo, Brandilyn A. Peters, ... Qibin Qi in Genome Medicine
    Article Open access 20 April 2024
  12. Effect of treatment regimen of the rheumatoid arthritis patients on the risk of coronavirus disease 2019 by modulating the inflammatory mediators

    Background

    The therapeutic profile of the patients with rheumatoid arthritis (RA) commonly consists of immunosuppressive and anti-inflammatory...

    Zahra Bagheri‑Hosseinabadi, Alireza Dehghani, ... Mitra Abbasifard in Inflammopharmacology
    Article 15 July 2023
  13. Anakinra in Sanfilippo syndrome: a phase 1/2 trial

    Sanfilippo syndrome is a fatal childhood neurodegenerative disorder involving neuroinflammation among multiple pathologies. We hypothesized that...

    Lynda E. Polgreen, Agnes H. Chen, ... Julie B. Eisengart in Nature Medicine
    Article Open access 21 June 2024
  14. Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data

    Nowadays, the biological equipment available for the treatment of moderate-to-severe psoriasis is plenty. Anti-interleukin-23 represents the latest...

    Angelo Ruggiero, Matteo Megna, ... Sonia Sofia Ocampo-Garza in Immunologic Research
    Article 04 January 2023
  15. Targeting STING in dendritic cells alleviates psoriatic inflammation by suppressing IL-17A production

    Psoriasis is a common chronic inflammatory skin disease driven by the aberrant activation of dendritic cells (DCs) and T cells, ultimately leading to...

    **aoying Sun, Liu Liu, ... **n Li in Cellular & Molecular Immunology
    Article 28 May 2024
  16. First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours

    Background

    Interleukin-1 (IL-1) signalling is involved in various protumoural processes including proliferation, immune evasion, metastasis and...

    Debbie Robbrecht, Christiane Jungels, ... Ahmad Awada in British Journal of Cancer
    Article 13 December 2021
  17. Differential effects of two phosphodiesterase 4 inhibitors against lipopolysaccharide-induced neuroinflammation in mice

    Background

    Several phosphodiesterase 4 (PDE4) inhibitors have emerged as potential therapeutics for central nervous system (CNS) diseases. This study...

    Dong Ho Kang, Sunjoo Ahn, ... ** Sook Song in BMC Neuroscience
    Article Open access 31 July 2023
  18. Correction to: Critical role of interleukin-23 in development of asthma promoted by cigarette smoke

    The original publication of this paper contains a mistake.

    Hyun Seung Lee, Da-Eun Park, ... Sang-Heon Cho in Journal of Molecular Medicine
    Article 22 May 2019
  19. The ameliorative effects of topical gemifloxacin alone or in combination with clobetasol propionate on imiquimod-induced model of psoriasis in mice

    Psoriasis is a lifelong immune-driven skin condition characterized by excessive epidermal overgrowth and inflammatory cell infiltration. Gemifloxacin...

    Hayder Ridha Salman, Adeeb Ahmed Al-Zubaidy, ... Qassim A. Zigam in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 25 July 2023
  20. Interleukin-23 receptor signaling mediates cancer dormancy and radioresistance in human esophageal squamous carcinoma cells via the Wnt/Notch pathway

    Abstract

    In the tumor microenvironment, inflammatory cells and molecules influence almost every process; among them, interleukin-23 (IL-23) is a...

    Yuepeng Zhou, Yuting Su, ... Deyu Chen in Journal of Molecular Medicine
    Article Open access 27 November 2018
Did you find what you were looking for? Share feedback.